‘Kenya among nations running out of ARVs’

Eight countries, among them Kenya, Nigeria and Lesotho, could soon run out of HIV drugs following US government’s recent decision to pause foreign aid, WHO has said.

However, Kenya’s Ministry of Health says the country has enough ARVs to last four months.

More shipments are on the way, raising Kenya’s ARV stock to enough levels until June.

US President Donald Trump announced the freeze on his first day in office in January, as part of a review into government spending.

“Disruptions to HIV programmes could undo 20 years of progress,” WHO chief Tedros Ghebreyesus said at a press conference on Monday.

It could also lead to more than 10 million additional cases of HIV and three million HIV-related deaths, he added, noting that this is “more than triple the number of deaths last year”.

Nigeria, Kenya, Lesotho, South Sudan, Burkina Faso, Mali, Haiti and Ukraine would run out of life-saving anti-retroviral medicines in the coming months, Tedros said.

Trump’s executive order paused foreign aid support for an initial duration of 90 days in line with his “America First” foreign policy.

It has affected health programmes around the world, leaving shipments of critical medical supplies, including HIV drugs, greatly hampered.

The majority of the US Agency for International Development’s programmes have since been terminated.

Despite a waiver issued in February for the US’s ground-breaking HIV programme, its work has been severely impacted.

Known as the US President’s Emergency Plan for Aids Relief (Pepfar), it relies on logistical support from USAID and other organisations hit by the turmoil.

It has led to the “immediate stop to services for HIV treatment, testing and prevention in more than 50 countries”.

Launched in 2003, Pepfar has enabled some of the world’s poorest people to access anti-retroviral drugs and has been credited with saving more than 26 million lives worldwide.

During his first days in office, Trump also announced that the US would pull out of the WHO, affecting funding for the global health agency.

“The US administration has been extremely generous over many years. And of course, it’s within its rights to decide what it supports and to what extent,” Tedros said.

“But the US also has a responsibility to ensure that if it withdraws direct funding for countries, it’s done in an orderly and humane way that allows them to find alternative sources of funding.”

An estimated 25 million people are living with HIV in sub-Saharan Africa, which is more than two thirds of the global total 38 million people living with the disease.

In Nigeria, nearly two million people are living with HIV, with many relying on receiving aid-funded medicines.

Kenya has the seventh-largest number of people living with HIV in the world, at around 1.4 million, according to WHO data.

“We ask the US to reconsider its support for global health, which not only saves lives around the world, it also makes the US safer by preventing outbreaks from spreading internationally,” Dr Tedros said.

Last week, MoH said the country has nearly five months of stock of the commonly used ARVs, known as TLD, a combination of Tenofovir/ Lamivudine/Dolutegravir.